ArticleJournal of thoracic disease2024

Efficacy and safety analysis of immune checkpoint inhibitor rechallenge therapy in locally advanced and advanced non-small cell lung cancer: a retrospective study.

Xiaoqi Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.